MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS

Clinical trials for MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS explained in plain language.

Never miss a new study

Get alerted when new MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS trials appear

Sign up with your email to follow new studies for MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New shot could ease arthritis pain for millions

Disease control Completed

This study tested a drug called CT-P13, given as a shot under the skin, in 192 adults with moderate-to-severe rheumatoid arthritis. The goal was to see if it reduces joint pain and swelling better than a placebo. Participants received either the drug or a dummy shot, and neither …

Matched conditions: MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS

Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control

Last updated May 26, 2026 08:20 UTC

MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS

Get alerted when new MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS trials appear

New shot could ease arthritis pain for millions